Variant report
Variant | esv1841089 |
---|---|
Chromosome Location | chr9:22666462-22680915 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BRCA1 | chr9:22669815-22669872 | Hela-S3 | cervix: | n/a | n/a |
2 | NFYA | chr9:22668235-22668410 | GM12878 | blood: | n/a | n/a |
3 | POLR2A | chr9:22667579-22667860 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | POLR2A | chr9:22672499-22672658 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | POLR2A | chr9:22669062-22669260 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | ZNF143 | chr9:22669275-22669563 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | ZNF143 | chr9:22673461-22673473 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DMRTA1-1 | chr9:22674434-22674694 | NONHSAT130441 |
2 | lnc-DMRTA1-2 | chr9:22674442-22674642 | ENSG00000234840.1 |
3 | lnc-DMRTA1-10 | chr9:22672609-22672712 | l_3742_chr9:22664441-22713435_adipose |
4 | lnc-DMRTA1-1 | chr9:22674481-22674642 | NONHSAT130443 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000234840 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185433880 | chr9:22666469-22666470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs5896995 | chr9:22666526-22666527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs35713803 | chr9:22666535-22666536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142985618 | chr9:22666541-22666542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs571268887 | chr9:22666549-22666550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533524634 | chr9:22666580-22666581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554079632 | chr9:22666594-22666595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574009991 | chr9:22666626-22666627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557269835 | chr9:22666661-22666662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556721898 | chr9:22666686-22666687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576521609 | chr9:22666709-22666710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189203073 | chr9:22666747-22666748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565229000 | chr9:22666754-22666755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192865461 | chr9:22666755-22666756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs117366445 | chr9:22666843-22666844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs671458 | chr9:22666900-22666901 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs561228440 | chr9:22666916-22666917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs116788124 | chr9:22666921-22666922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549250592 | chr9:22666928-22666929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184718540 | chr9:22666977-22666978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577393289 | chr9:22667057-22667058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551483037 | chr9:22667058-22667059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376886655 | chr9:22667095-22667096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533608670 | chr9:22667099-22667100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143267077 | chr9:22667106-22667107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375396030 | chr9:22667107-22667108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188648662 | chr9:22667109-22667110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374804271 | chr9:22667125-22667126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371561003 | chr9:22667203-22667204 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1020463 | chr9:22667225-22667226 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs375366664 | chr9:22667226-22667227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536560566 | chr9:22667236-22667237 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs181121435 | chr9:22667252-22667253 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576622884 | chr9:22667282-22667283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs146457976 | chr9:22667302-22667303 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554246740 | chr9:22667323-22667324 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538834389 | chr9:22667333-22667334 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146113346 | chr9:22667347-22667348 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530278203 | chr9:22667359-22667360 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572584376 | chr9:22667386-22667387 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs74484649 | chr9:22667389-22667390 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7853729 | chr9:22667399-22667400 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574842994 | chr9:22667406-22667407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374678748 | chr9:22667501-22667502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs376481630 | chr9:22667525-22667526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562619764 | chr9:22667576-22667577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545962316 | chr9:22667583-22667584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs73446540 | chr9:22667608-22667609 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs551302662 | chr9:22667633-22667634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs76523483 | chr9:22667643-22667644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Glioma | 20126413 | CNVD |
Melanoma | 17363583 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Cancer | 20581869 | CNVD |
Oral cancer | 22144094 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:22661400-22670600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr9:22664600-22667200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr9:22667200-22667400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr9:22667400-22668000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr9:22668000-22668200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr9:22668800-22671000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr9:22669400-22669600 | ZNF genes & repeats | iPS-18 Cell Line | embryonic stem cell |
8 | chr9:22669600-22672000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
9 | chr9:22670600-22672000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr9:22671000-22680800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr9:22671200-22672200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr9:22671800-22672600 | Enhancers | H9 Cell Line | embryonic stem cell |
13 | chr9:22671800-22673000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr9:22672000-22672800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr9:22672000-22672800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
16 | chr9:22672000-22673000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
17 | chr9:22672000-22673200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr9:22672000-22676400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr9:22672200-22673000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
20 | chr9:22672200-22674600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
21 | chr9:22674600-22678000 | Strong transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
22 | chr9:22675200-22682800 | Weak transcription | Liver | Liver |
23 | chr9:22676400-22678400 | Strong transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
24 | chr9:22678000-22681000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
25 | chr9:22678400-22682000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
26 | chr9:22679000-22687800 | Weak transcription | Pancreas | Pancrea |
27 | chr9:22680800-22681600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |